SEP
ZBH icon

Signature Equity Partners’s Zimmer Biomet ZBH Stock Holding History

Signature Equity Partners’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2
Closed -$180 – 1663
2025
Q4 		$180 Buy
+2
New +$190 ﹤0.01% 1645

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Signature Equity Partners's ZBH Position: Q1 2026 in Review

Signature Equity Partners sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 2 shares — an estimated $180 sold.

Signature Equity Partners first reported a position in ZBH in Q4 2025 and held it in 1 quarter. The position peaked at $180 in Q4 2025. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Signature Equity Partners reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
  • Signature Equity Partners sold 2 Zimmer Biomet shares in Q1 2026, an estimated $180.
  • Signature Equity Partners first reported a position in Zimmer Biomet in Q4 2025 and held it in 1 quarter.
  • Signature Equity Partners's Zimmer Biomet position peaked at $180 in Q4 2025.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Signature Equity Partners's 13F filing for Q1 2026, filed 13 May 2026.